Survival of patients with transformed lymphoma in the rituximab era

Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group

(2013) Diego Villa et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence, risk factors and outcome of histological transformation in follicular lymphoma

(2012) Annarita Conconi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Transformation of follicular lymphoma

(2011) Izidore S. Lossos et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Transformation of Indolent B-Cell Lymphomas

(2011) Silvia Montoto et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

(2010) Gilles Salles et al.   LANCET

The incidence, natural history, biology, and treatment of transformed lymphomas

(2009) S. H. Bernstein et al.   Hematology-American Society of Hematology Education Program

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

(2008) Abdulwahab J. Al-Tourah et al.   JOURNAL OF CLINICAL ONCOLOGY

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

(2008) Michael Pfreundschuh et al.   LANCET ONCOLOGY